Research, News & Discoveries

  • Vanderbilt University

    Curriculum Revision Builds a Foundation for Ph.D. Students to Succeed

    An essential component of a graduate student’s training is the first-year coursework, which fosters the skills needed to be an independent researcher, such as critical literature analysis, the ability to understand the current state of a given field, and hypothesis generation. In the spring of 2020, a committee comprising faculty… Read More

    Aug. 30, 2022

  • Vanderbilt University

    Basic Sciences faculty and staff join Vanderbilt Leadership Academy, Vanderbilt Leadership Enrichment classes

    Alyssa Hasty (associate dean for faculty, School of Medicine Basic Sciences), Claudia Paz (chief business officer, School of Medicine Basic Sciences), Tiffany Lawrence Givens (director of human resources, Basic Sciences Dean’s Office, School of Medicine), and Kimberly D. Turner (assistant dean of administrative operations, School of Medicine Basic Sciences) have been named to… Read More

    Aug. 25, 2022

  • Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. Dr. Crowe is the subject of a feature article in the upcoming Winter 2018 issue of Vanderbilt Magazine. Crowe, who is the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology, as well as director of the Vanderbilt Vaccine Center, has spent his career hunting for a universal flu vaccine. He has re-engineered how flu vaccines work and is on the edge of creating a single shot that covers all flu strains. In a new initiative announced in October, he will lead an international team of researchers as they launch clinical trials of his new vaccine.(John Russell/Vanderbilt University)

    COVID antibody research conducted at VUMC lands national award

    A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals, and which was optimized and developed by the global pharmaceutical company AstraZeneca, has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine. Now… Read More

    Aug. 25, 2022

  • Vanderbilt University

    New high-tech biobank safeguards critical specimens

    Vanderbilt University Medical Center has opened a state-of-the-art automated biobanking system that can store as many as 10 million biospecimens, including blood and body fluids, tissue, and genetic and protein material, at temperatures down to minus 80 degrees Celsius. The “BioStore” was purchased from its manufacturer, Massachusetts-based Azenta Life… Read More

    Aug. 25, 2022

  • Vanderbilt University

    Nanoparticles boost anti-cancer immunity

    The growth of epithelial ovarian cancer, one of the most lethal malignancies, is associated with the presence of tumor-associated macrophages (TAMs), white blood cells that can block the anti-cancer activity of the immune system and immunotherapy. Fortunately, TAMs can be “repolarized,” converted from immunosuppressive tumor-promoters to inflammatory tumor-fighters. Now,… Read More

    Aug. 18, 2022

  • Leveraging the structure of bacterial host cell receptors to detect cancer

    Leveraging the structure of bacterial host cell receptors to detect cancer

    Bacteria in our bodies bind to various host cell surface receptors, which determines where the bacteria live and how they behave. These receptors, made up of chains of sugar molecules called glycans, are more than meets the eye. Cells existing within progressive disease states like cancer can have an increased… Read More

    Aug. 16, 2022

  • Vanderbilt University

    A day in the lab with Caroline Cencer

    Spend a day in the Tyska lab with graduate student Caroline Cencer via this TikTok video! @CarolineCencer @TyskaLabActual… Read More

    Aug. 12, 2022

  • Vanderbilt University

    Researchers create algorithm to help predict cancer risk associated with tumor variants

    Vanderbilt researchers have developed an active machine learning approach to predict the effects of tumor variants of unknown significance, or VUS, on sensitivity to chemotherapy. VUS, mutated bits of DNA with unknown impacts on cancer risk, are constantly being identified. The growing number of rare VUS makes it imperative for… Read More

    Aug. 9, 2022

  • Vanderbilt University

    Billy Hudson’s Aspirnaut program featured on NBC Nightly News with Lester Holt on August 2nd.

    In Grapevine, Arkansas students spent more than two hours on the school bus every day for years. Local scientist Billy Hudson saw that time as an opportunity to create a “magic” school bus with internet and computers where students could spend time learning. Now, more than a decade later, Hudson… Read More

    Aug. 3, 2022

  • Vanderbilt University

    Researchers find potential new target against colorectal cancer

    Researchers at Vanderbilt University Medical Center have discovered a potential new target in the fight against colorectal cancer, the nation’s third most common malignancy and, next to lung cancer, the second leading cancer killer. This month in the journal Gastroenterology, R. Daniel Beauchamp, MD, Anna Means, PhD,… Read More

    Aug. 2, 2022